The goal of this clinical trial is to evaluate whether wet cupping therapy (Hijama) can improve reproductive and metabolic outcomes in women diagnosed with Polycystic Ovary Syndrome (PCOS). This study will be conducted among female participants aged 20-40 years who have been diagnosed with PCOS according to the Rotterdam criteria.
The main questions it aims to answer are:
Can wet cupping therapy regulate menstrual cycles in women with PCOS?
Can it increase the pregnancy rate in married participants with PCOS-related infertility?
Researchers will compare outcomes between a wet cupping group and a control group to determine whether Hijama has significant effects on reproductive, hormonal, and metabolic markers.
Participants will:
Undergo screening and eligibility evaluation using a checklist
Be randomized into either the wet cupping (intervention) or control group
Receive lifestyle counseling (diet and physical activity)
For the intervention group:
Receive one Hijama session performed by a certified practitioner
Undergo follow-up at 4 and 12 weeks for clinical, hormonal, and ultrasound assessments
For all participants:
Complete laboratory tests, ultrasound scans, and questionnaires on PCOS symptoms and quality of life
Report any side effects during and after the study period
Female participants.
Aged 20 to 40 years.
Diagnosed with Polycystic Ovary Syndrome (PCOS) according to the Rotterdam criteria.
Willing to participate in the study and provide informed consent.
Known diagnosis of uncontrolled thyroid dysfunction.
Diagnosis of diabetes mellitus.
Elevated FSH levels above 20 mIU/mL.
Hyperprolactinemia with serum levels above 1000 mIU/L.